Bioactive actions of pomegranate fruit extracts on leukemia cell lines in vitro hold promise for new therapeutic agents for leukemia

Nutrition and Cancer

Volumn 64, Issue 1, 2012, Pages 100-110

  Dahlawi, Haytham ^a   Jordan Mahy, Nicola ^a   Clench, Malcolm R ^a   Le Maitre, Christine L ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4' 6 DIAMIDINO 2 PHENYLINDOLE; INDOLE DERIVATIVE; LIPOCORTIN 5; POMEGRANATE EXTRACT; PROPIDIUM IODIDE; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL COUNT; CELL CYCLE; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA CONTENT; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMIA; LIVER CELL; LYMPHOID CELL; OSMOLARITY; PH MEASUREMENT; POMEGRANATE; SENSITIVITY ANALYSIS; STAINING;

ANNEXINS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL DEATH; DRUG SCREENING ASSAYS, ANTITUMOR; FLUORESCENT DYES; HYDROGEN-ION CONCENTRATION; INDOLES; LEUKEMIA; PLANT EXTRACTS; PUNICACEAE; TUMOR CELLS, CULTURED;

LYTHRACEAE;

EID: 84856928858     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.630155     Document Type: Article

References (37)

1. McCance KL, Huether SE, Brashers VL, and Rote NS: Pathophysiology the Biologic Basic of Diseases in Adults and Children, 6th ed. Elsevier's Health Science, Philadelphia, 2010.
2. Vardiman JW: The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: An overviewwith emphasis on the myeloid neoplasms. Chem Biol Interact 184, 16-20, 2010.
3. Cancer Research UK: Cancer incidence-UK statistics. Retrieved from http://info.cancerresearchuk.org/cancerstats/incidence/index.htm
4. Fielding LP, Fenoglio-Preiser CM, and Freedman LS: The future of prognostic factors in outcome prediction for patients with cancer. Cancer 70, 2367-2377, 1992.
5. Banfi A, Podest̀a M, Fazzuoli L, Roberto Sertoli M, Venturini M,.et al. High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors. Cancer 92, 2419-2428, 2001.
6. Aksentijevich I and Flinn I. Chemotherapy and bone marrow reserve: Lessons learned from autologous stem cell transplantation. Cancer Biother Radiopharma 17, 399-403, 2002.
7. Yetgin S, Olgar Ş , Aras T, Ç etin M, D̈uzova A,.et al. Evaluation of kidney damage in patients with acute lymphoblastic leukemia in long-term followup: value of renal scan. Am J Hematol 77, 132-139, 2004. (Pubitemid 39281856)
8. Deng CH and Zhang QP: Leukemia stem cells in drug resistance and metastasis. Chin Med J (Engl) 123, 954-960, 2010.
9. Aggarwal BB and Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71, 1397-1421,2006.
10. Khan N, Adhami VM, and Mukhtar H. Apoptosis by dietary agents for prevention and treatment of cancer. Biochem Pharmacol 76, 1333-1339, 2008.
11. Langley P. Why a pomegranate? Br Med J 321, 1153, 2000.
12. Lansky EP andNewman RA: Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol 109, 177-206, 2007. (Pubitemid 44959707)
13. Gil MI, Toḿas-Barbeŕan FA, Hess-Pierce B, Holcroft DM, and Kader AA: Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 48, 4581-4589, 2000.
14. Wolfe KL, Kang X, He X, Dong M, Zhang Q,.et al. Cellular antioxidant activity of common fruits. J Agric Food Chem 56, 8418-8426, 2008.
15. Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D,.et al. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem 54, 980-985, 2006. (Pubitemid 43274141)
16. Kim ND, Mehta R, Yu W, Neeman I, Livney T,.et al. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat 71, 203-217, 2002. (Pubitemid 34263985)
17. Khan N and Mukhtar H. Pomegranate fruit as a lung cancer chemopreventive agent. Drug Future 32, 549-554, 2007. (Pubitemid 47234745)
18. Lansky EP, Harrison G, Froom P, and Jiang WG: Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel. Invest New Drugs 23, 121-122, 2005. (Pubitemid 40386228)
19. Afaq F, Saleem M, Krueger CG, Reed JD, and Mukhtar H. Anthocyaninand hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-κB pathways and inhibits skin tumorigenesis in CD-1 mice. Int J Cancer 113, 423-433, 2005. (Pubitemid 40038710)
20. Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN,.et al. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci USA 102, 14813, 2005.
21. Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y,.et al. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 16, 360-367, 2005. (Pubitemid 40776045)
22. Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J,.et al. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res 12, 4018, 2006.
23. Kawaii S and Lansky EP: Differentiation-promoting activity of pomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells. J Med Food 7, 13-18, 2004. (Pubitemid 38445916)
24. Khan GN, Gorin MA, Rosenthal D, Pan Q, Bao LW,.et al. Pomegranate fruit extract impairs invasion and motility in human breast cancer. Integ Cancer Ther 8, 242, 2009.
25. Kasimsetty SG, Bialonska D, Reddy MK,Ma G, Khan SI,.et al. Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J Agric Food Chem 58, 2180-2187, 2010.
26. Herst PM, Davis JE, Neeson P, Berridge MV, and Ritchie DS: The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells. Haematologica 94, 928, 2009.
27. Zaini R, Clench MR, and Le Maitre CL: Bioactive chemicals from carrots( Daucus Carota) juice extracts from the treatment of leukaemia. J Med Food, in press.
28. White DL and Hughes TP: Predicting the response of CML patients to tyrosine kinase inhibitor therapy. Curr Hema Malignancy Reports 4, 59-65, 2009.
29. Schmitt CA: Cellular senescence and cancer treatment. Biochimica Biophysica Acta 1775, 5-20, 2007. (Pubitemid 44881196)
30. Anfossi G, Gewirtz AM, and Calabretta B. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc Nat Aca Sci 86, 3379, 1989.
31. Mertens-Talcott SU, Talcott ST, and Percival SS: Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. J Nutr 133, 2669, 2003.
32. Zhu H, Zhang L, and Wu S. Induction of S-phase arrest and p21 overexpression by a small molecule 2 [[3-(2, 3-dichlorophenoxy) propyl] amino] ethanol in correlation with activation of ERK. Oncogene 23, 4984-4992, 2004. (Pubitemid 38938731)
33. Rapizzi E, Fossati S, Moroni F, and Chiargugi A: Inhibition of poly(ADP-ribose) glycohydrolase by gallotannin selectively up regulates expression of proinflammatory genes. Mol Pharmacol 66, 890-898, 2004. (Pubitemid 39319461)
34. Larrosa M, Toḿas-Barbeŕan FA, and Esṕin JC: The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J Nutr Biochem 17, 611-625, 2006. (Pubitemid 44205438)
35. Hong MY, Seeram NP, and Heber D. Pomegranate polyphenols downregulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor. JNutrBiochem 19, 848-855, 2008.
36. Koyama S, Cobb LJ, Mehta HH, Seeram NP, Heber D,.et al. Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis. Growth Hormone IGF Res 20, 55-62, 2010.
37. Rettig MB, Heber D, An J, Seeram NP, Rao JY,.et al. Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-κB-dependent mechanism. Mol Cancer Ther 7, 2662, 2008.